The large-scale placebo-controlled beta-blocker studies in systolic heart failure revisited: Results from CIBIS-II, COPERNICUS and SENIORS-SHF compared with stratified subsets from MERIT-HF

Journal of Internal Medicine

Volumn 275, Issue 2, 2014, Pages 134-143

  Wikstrand, J ^a   Wedel, H ^b   Castagno, D ^c   Mcmurray, J J V ^d  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b NORDIC SCHOOL OF PUBLIC HEALTH   (Sweden)

^c UNIVERSITY OF TURIN   (Italy)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Beta blockers; Clinical trials; Heart failure

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BISOPROLOL; CARVEDILOL; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METOPROLOL; NEBIVOLOL; PLACEBO;

ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CONGESTIVE HEART FAILURE; DRUG DOSE INCREASE; DRUG DOSE TITRATION; HEART EJECTION FRACTION; HOSPITALIZATION; HUMAN; NEW YORK HEART ASSOCIATION CLASS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECOMMENDED DRUG DOSE; RISK REDUCTION; SURVIVAL; SYSTOLIC HEART FAILURE;

BETA-BLOCKERS; CLINICAL TRIALS; HEART FAILURE;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; BENZOPYRANS; BISOPROLOL; CARBAZOLES; DELAYED-ACTION PREPARATIONS; ETHANOLAMINES; FEMALE; HEART FAILURE, SYSTOLIC; HOSPITALIZATION; HUMANS; MALE; METOPROLOL; MIDDLE AGED; PROPANOLAMINES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; TREATMENT OUTCOME;

EID: 84892557932     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/joim.12141     Document Type: Article

References (11)

1. CIBIS-II Investigators and Committees. The cardiac insufficiency bisoprolol study II (CIBIS II). Lancet 1999; 353: 9-13.
2. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomized Intervention Trial In Congestive Heart Failure (MERIT-HF). Lancet 1999; 353: 2001-7.
3. Hjalmarson Å, Goldstein S, Fagerberg Bet al. for the MERIT-HF study Group. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure. The Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF). JAMA 2000; 283: 1295-302.
4. Packer M, Coats AJS, Fowler MB et al. for the Carvedilol Prospective Randomized Cumulative Survival Study Group. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001; 344: 1651-8.
5. Packer M, Fowler MB, Roecker EB et al. for Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study Group. Effect of carvedilol on the morbitity of patients with severe chronic heart failure. Circulation 2002; 106: 2194-9.
6. Flather MD, Shibata MC, Coats JS et al. for the SENIORS Investigators. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J 2005; 26: 215-25.
7. Veldhuisen DJ, Cohen-Solal A, Böhm M et al. on behalf of the SENIORS investigators. Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction. J Am Coll Cardiol 2009; 53: 2150-8.
8. Ghali JK, Wikstrand J, Veldhuisen DJ et al. for the MERIT-HF study group. The influence of renal function on clinical outcome and response to beta-blockade in systolic heart failure. J Cardiac Fail 2009; 15: 310-8.
9. Wikstrand J, Andersson B, Kendall MJ, Stanbrook H, Klibaner M. Pharmacokinetic considerations of formulation: extended-release metoprolol succinate in the treatment of heart failure. J Cardiovasc Pharmacol 2003; 41: 151-7.
10. Wedel H, McMurray JJV, Lindberg M et al. for the CORONA Study Group. Predictors of fatal and nonfatal outcomes in the Controlled Rosuvastatin Multinational trial in heart failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptide. Eur J of Heart Fail 2009; 11: 281-91.
11. Flannery G, Gehrig-Mills R, Billah B, Krum H. Analysis of randomized controlled trials on the effect of magnitude of heart rate reduction on clinical outcomes in patients with systolic chronic heart failure receiving beta-blockers. Am J Cardiol 2008; 101: 865-9.